Velan Capital Investment Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-55,300	Closed	-$3.15M	–	28
2023 Q3	$3.15M	Hold	55,300	–	–	2.54%	10
2023 Q2	$2.82M	Buy	55,300 +31,900	+136%	+$1.63M	2.62%	15
2023 Q1	$501K	Buy	+23,400	New	+$501K	0.43%	26